Lantheus Holdings, Inc. (LNTH): Price and Financial Metrics

Lantheus Holdings, Inc. (LNTH): $62.24

1.78 (+2.94%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

LNTH Price/Volume Stats

Current price $62.24 52-week high $100.85
Prev. close $60.46 52-week low $50.20
Day low $60.30 Volume 1,030,600
Day high $62.47 Avg. volume 1,150,026
50-day MA $58.47 Dividend yield N/A
200-day MA $68.04 Market Cap 4.27B

LNTH Stock Price Chart Interactive Chart >

LNTH POWR Grades

  • Quality is the dimension where LNTH ranks best; there it ranks ahead of 90.37% of US stocks.
  • LNTH's strongest trending metric is Stability; it's been moving down over the last 26 weeks.
  • LNTH ranks lowest in Momentum; there it ranks in the 4th percentile.

LNTH Stock Summary

  • With a price/earnings ratio of 41.29, LANTHEUS HOLDINGS INC P/E ratio is greater than that of about 82.07% of stocks in our set with positive earnings.
  • With a year-over-year growth in debt of 235.23%, LANTHEUS HOLDINGS INC's debt growth rate surpasses 96.15% of about US stocks.
  • Revenue growth over the past 12 months for LANTHEUS HOLDINGS INC comes in at 50.43%, a number that bests 91.01% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to LANTHEUS HOLDINGS INC are KZIA, SDGR, LQDA, PXLW, and FEMY.
  • Visit LNTH's SEC page to see the company's official filings. To visit the company's web site, go to www.lantheus.com.

LNTH Valuation Summary

  • In comparison to the median Healthcare stock, LNTH's price/sales ratio is 59.09% higher, now standing at 3.5.
  • Over the past 104 months, LNTH's EV/EBIT ratio has gone up 22.6.

Below are key valuation metrics over time for LNTH.

Stock Date P/S P/B P/E EV/EBIT
LNTH 2023-12-29 3.5 6.1 40.8 36.8
LNTH 2023-12-28 3.5 6.1 41.0 37.0
LNTH 2023-12-27 3.5 6.0 40.5 36.5
LNTH 2023-12-26 3.5 6.0 40.2 36.3
LNTH 2023-12-22 3.4 5.8 39.2 35.4
LNTH 2023-12-21 3.4 5.8 39.0 35.2

LNTH Growth Metrics

    The 5 year price growth rate now stands at 1.16%.
  • The 4 year net income to common stockholders growth rate now stands at 21.76%.
  • Its 4 year revenue growth rate is now at 14.6%.
Over the past 33 months, LNTH's revenue has gone up $454,120,000.

The table below shows LNTH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 801.457 190.318 107.037
2022-06-30 664.238 101.09 32.39
2022-03-31 541.579 54.362 -37.325
2021-12-31 425.208 53.916 -71.279
2021-09-30 389.798 40.596 -34.476
2021-06-30 376.269 44.831 -27.447

LNTH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • LNTH has a Quality Grade of C, ranking ahead of 29.96% of graded US stocks.
  • LNTH's asset turnover comes in at 0.436 -- ranking 105th of 682 Pharmaceutical Products stocks.
  • AVDL, OTIC, and SYRS are the stocks whose asset turnover ratios are most correlated with LNTH.

The table below shows LNTH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.436 0.431 -0.030
2021-03-31 0.393 0.416 0.016
2020-12-31 0.448 0.409 -0.004
2020-09-30 0.521 0.432 0.006
2020-06-30 0.634 0.452 0.034
2020-03-31 0.877 0.480 0.075

LNTH Price Target

For more insight on analysts targets of LNTH, see our LNTH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $32.00 Average Broker Recommendation 1.17 (Strong Buy)

Lantheus Holdings, Inc. (LNTH) Company Bio


Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide. The company was founded in 1956 and is based in North Billerica, Massachusetts.


LNTH Latest News Stream


Event/Time News Detail
Loading, please wait...

LNTH Latest Social Stream


Loading social stream, please wait...

View Full LNTH Social Stream

Latest LNTH News From Around the Web

Below are the latest news stories about LANTHEUS HOLDINGS INC that investors may wish to consider to help them evaluate LNTH as an investment opportunity.

New Year, New Gains: The 3 Best AI Stocks to Buy in 2024

These AI stocks offer substantial upside potential compared to the overextended chip players that dominated the theme in 2023.

Omor Ibne Ehsan on InvestorPlace | January 1, 2024

13 Most Promising Future Stocks To Buy According To Hedge Funds

In this piece, we will take a look at the 13 most promising stocks to buy according to hedge funds. If you want to skip our overview of the latest stock market news, then you can take a look at the 5 Most Promising Future Stocks To Buy. Investing, for the most part, is all […]

Yahoo | December 27, 2023

Lantheus Holdings Is Charting a Path to Sustainable Growth and Value

Evaluating a leader in the global precision diagnostics market

Yahoo | December 20, 2023

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer

Phase 3 SPLASH study of 177Lu-PNT2002 demonstrated statistically significant improvement in radiographic progression-free survival (rPFS) BEDFORD, Mass., and INDIANAPOLIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- December 18, 2023 – Lantheus Holdings, Inc. (Lantheus) (NASDAQ: LNTH) and POINT Biopharma Global Inc. (POINT) (NASDAQ: PNT) today announced statistically significant topline results from the pivotal Phase 3 SPLASH study evaluating the efficacy and safety of 177Lu-PNT2002, a prostate-specific m

Yahoo | December 18, 2023

Lantheus Holdings (LNTH) Crossed Above the 200-Day Moving Average: What That Means for Investors

Should investors be excited or worried when a stock crosses above the 200-day simple moving average?

Yahoo | December 15, 2023

Read More 'LNTH' Stories Here

LNTH Price Returns

1-mo -4.79%
3-mo 0.39%
6-mo -10.42%
1-year -22.89%
3-year 187.35%
5-year 154.25%
YTD 0.39%
2023 21.66%
2022 76.39%
2021 114.16%
2020 -34.23%
2019 31.05%

Continue Researching LNTH

Here are a few links from around the web to help you further your research on Lantheus Holdings Inc's stock as an investment opportunity:

Lantheus Holdings Inc (LNTH) Stock Price | Nasdaq
Lantheus Holdings Inc (LNTH) Stock Quote, History and News - Yahoo Finance
Lantheus Holdings Inc (LNTH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!